2024-09-012025-08-312025-08-31false09653844Homerton Sports and Musculoskeletal Medicine Limited2026-05-13falseiso4217:GBPxbrli:pure096538442024-08-31096538442025-08-31096538442024-09-012025-08-31096538442023-08-31096538442024-08-31096538442023-09-012024-08-3109653844bus:SmallEntities2024-09-012025-08-3109653844bus:AuditExempt-NoAccountantsReport2024-09-012025-08-3109653844bus:FullAccounts2024-09-012025-08-3109653844bus:PrivateLimitedCompanyLtd2024-09-012025-08-3109653844core:WithinOneYear2025-08-3109653844core:AfterOneYear2025-08-3109653844core:WithinOneYear2024-08-3109653844core:AfterOneYear2024-08-3109653844core:ShareCapital2025-08-3109653844core:SharePremium2025-08-3109653844core:RevaluationReserve2025-08-3109653844core:OtherReservesSubtotal2025-08-3109653844core:RetainedEarningsAccumulatedLosses2025-08-3109653844core:ShareCapital2024-08-3109653844core:SharePremium2024-08-3109653844core:RevaluationReserve2024-08-3109653844core:OtherReservesSubtotal2024-08-3109653844core:RetainedEarningsAccumulatedLosses2024-08-3109653844core:LandBuildings2025-08-3109653844core:PlantMachinery2025-08-3109653844core:Vehicles2025-08-3109653844core:FurnitureFittings2025-08-3109653844core:OfficeEquipment2025-08-3109653844core:NetGoodwill2025-08-3109653844core:IntangibleAssetsOtherThanGoodwill2025-08-3109653844core:ListedExchangeTraded2025-08-3109653844core:UnlistedNon-exchangeTraded2025-08-3109653844core:LandBuildings2024-08-3109653844core:PlantMachinery2024-08-3109653844core:Vehicles2024-08-3109653844core:FurnitureFittings2024-08-3109653844core:OfficeEquipment2024-08-3109653844core:NetGoodwill2024-08-3109653844core:IntangibleAssetsOtherThanGoodwill2024-08-3109653844core:ListedExchangeTraded2024-08-3109653844core:UnlistedNon-exchangeTraded2024-08-3109653844core:LandBuildings2024-09-012025-08-3109653844core:PlantMachinery2024-09-012025-08-3109653844core:Vehicles2024-09-012025-08-3109653844core:FurnitureFittings2024-09-012025-08-3109653844core:OfficeEquipment2024-09-012025-08-3109653844core:NetGoodwill2024-09-012025-08-3109653844core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3109653844core:ListedExchangeTraded2024-09-012025-08-3109653844core:UnlistedNon-exchangeTraded2024-09-012025-08-3109653844core:MoreThanFiveYears2024-09-012025-08-3109653844core:Non-currentFinancialInstruments2025-08-3109653844core:Non-currentFinancialInstruments2024-08-3109653844dpl:CostSales2024-09-012025-08-3109653844dpl:DistributionCosts2024-09-012025-08-3109653844core:LandBuildings2024-09-012025-08-3109653844core:PlantMachinery2024-09-012025-08-3109653844core:Vehicles2024-09-012025-08-3109653844core:FurnitureFittings2024-09-012025-08-3109653844core:OfficeEquipment2024-09-012025-08-3109653844dpl:AdministrativeExpenses2024-09-012025-08-3109653844core:NetGoodwill2024-09-012025-08-3109653844core:IntangibleAssetsOtherThanGoodwill2024-09-012025-08-3109653844dpl:GroupUndertakings2024-09-012025-08-3109653844dpl:ParticipatingInterests2024-09-012025-08-3109653844dpl:GroupUndertakingscore:ListedExchangeTraded2024-09-012025-08-3109653844core:ListedExchangeTraded2024-09-012025-08-3109653844dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-09-012025-08-3109653844core:UnlistedNon-exchangeTraded2024-09-012025-08-3109653844dpl:CostSales2023-09-012024-08-3109653844dpl:DistributionCosts2023-09-012024-08-3109653844core:LandBuildings2023-09-012024-08-3109653844core:PlantMachinery2023-09-012024-08-3109653844core:Vehicles2023-09-012024-08-3109653844core:FurnitureFittings2023-09-012024-08-3109653844core:OfficeEquipment2023-09-012024-08-3109653844dpl:AdministrativeExpenses2023-09-012024-08-3109653844core:NetGoodwill2023-09-012024-08-3109653844core:IntangibleAssetsOtherThanGoodwill2023-09-012024-08-3109653844dpl:GroupUndertakings2023-09-012024-08-3109653844dpl:ParticipatingInterests2023-09-012024-08-3109653844dpl:GroupUndertakingscore:ListedExchangeTraded2023-09-012024-08-3109653844core:ListedExchangeTraded2023-09-012024-08-3109653844dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-09-012024-08-3109653844core:UnlistedNon-exchangeTraded2023-09-012024-08-3109653844core:NetGoodwill2025-08-3109653844core:IntangibleAssetsOtherThanGoodwill2025-08-3109653844core:LandBuildings2025-08-3109653844core:PlantMachinery2025-08-3109653844core:Vehicles2025-08-3109653844core:FurnitureFittings2025-08-3109653844core:OfficeEquipment2025-08-3109653844core:AfterOneYear2025-08-3109653844core:WithinOneYear2025-08-3109653844core:ListedExchangeTraded2025-08-3109653844core:UnlistedNon-exchangeTraded2025-08-3109653844core:ShareCapital2025-08-3109653844core:SharePremium2025-08-3109653844core:RevaluationReserve2025-08-3109653844core:OtherReservesSubtotal2025-08-3109653844core:RetainedEarningsAccumulatedLosses2025-08-3109653844core:NetGoodwill2024-08-3109653844core:IntangibleAssetsOtherThanGoodwill2024-08-3109653844core:LandBuildings2024-08-3109653844core:PlantMachinery2024-08-3109653844core:Vehicles2024-08-3109653844core:FurnitureFittings2024-08-3109653844core:OfficeEquipment2024-08-3109653844core:AfterOneYear2024-08-3109653844core:WithinOneYear2024-08-3109653844core:ListedExchangeTraded2024-08-3109653844core:UnlistedNon-exchangeTraded2024-08-3109653844core:ShareCapital2024-08-3109653844core:SharePremium2024-08-3109653844core:RevaluationReserve2024-08-3109653844core:OtherReservesSubtotal2024-08-3109653844core:RetainedEarningsAccumulatedLosses2024-08-3109653844core:NetGoodwill2023-08-3109653844core:IntangibleAssetsOtherThanGoodwill2023-08-3109653844core:LandBuildings2023-08-3109653844core:PlantMachinery2023-08-3109653844core:Vehicles2023-08-3109653844core:FurnitureFittings2023-08-3109653844core:OfficeEquipment2023-08-3109653844core:AfterOneYear2023-08-3109653844core:WithinOneYear2023-08-3109653844core:ListedExchangeTraded2023-08-3109653844core:UnlistedNon-exchangeTraded2023-08-3109653844core:ShareCapital2023-08-3109653844core:SharePremium2023-08-3109653844core:RevaluationReserve2023-08-3109653844core:OtherReservesSubtotal2023-08-3109653844core:RetainedEarningsAccumulatedLosses2023-08-3109653844core:AfterOneYear2024-09-012025-08-3109653844core:WithinOneYear2024-09-012025-08-3109653844core:Non-currentFinancialInstrumentscore:CostValuation2024-09-012025-08-3109653844core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-09-012025-08-3109653844core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-09-012025-08-3109653844core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-09-012025-08-3109653844core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-09-012025-08-3109653844core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-09-012025-08-3109653844core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3109653844core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3109653844core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-09-012025-08-3109653844core:Non-currentFinancialInstrumentscore:CostValuation2025-08-3109653844core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-08-3109653844core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-08-3109653844core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-08-3109653844core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-08-3109653844core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-08-3109653844core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-08-3109653844core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-08-3109653844core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-08-3109653844core:Non-currentFinancialInstrumentscore:CostValuation2024-08-3109653844core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-08-3109653844core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-08-3109653844core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-08-3109653844core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-08-3109653844core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-08-3109653844core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-08-3109653844core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-08-3109653844core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-08-3109653844bus:Director12024-09-012025-08-31

Homerton Sports and Musculoskeletal Medicine Limited

Registered Number
09653844
(England and Wales)

Unaudited Financial Statements for the Year ended
31 August 2025

Homerton Sports and Musculoskeletal Medicine Limited
Company Information
for the year from 1 September 2024 to 31 August 2025

Director

Carol Ann Resteghini

Registered Address

42 High Street, Wanstead
London
E11 2RJ

Registered Number

09653844 (England and Wales)
Homerton Sports and Musculoskeletal Medicine Limited
Balance Sheet as at
31 August 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets35,5006,050
5,5006,050
Current assets
Debtors435,266105
Cash at bank and on hand393,719633,150
428,985633,255
Creditors amounts falling due within one year5(58,011)(77,166)
Net current assets (liabilities)370,974556,089
Total assets less current liabilities376,474562,139
Net assets376,474562,139
Capital and reserves
Called up share capital500500
Profit and loss account375,974561,639
Shareholders' funds376,474562,139
The financial statements were approved and authorised for issue by the Director on 13 May 2026, and are signed on its behalf by:
Carol Ann Resteghini
Director
Registered Company No. 09653844
Homerton Sports and Musculoskeletal Medicine Limited
Notes to the Financial Statements
for the year ended 31 August 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Turnover policy
Turnover represents the net invoiced value of services rendered.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. Goodwill, being the amount paid in connection with the acquisition of a business in 2015, is being amortised evenly over its estimated useful life of twenty years.
2.Average number of employees

20252024
Average number of employees during the year11
3.Intangible assets

Goodwill

Total

££
Cost or valuation
At 01 September 2411,00011,000
At 31 August 2511,00011,000
Amortisation and impairment
At 01 September 244,9504,950
Charge for year550550
At 31 August 255,5005,500
Net book value
At 31 August 255,5005,500
At 31 August 246,0506,050
4.Debtors: amounts due within one year

2025

2024

££
Other debtors35,266-
Prepayments and accrued income-105
Total35,266105
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2025

2024

££
Amounts owed to related parties21,64141,862
Taxation and social security36,37035,304
Total58,01177,166
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.